Chemours CoCCEarnings & Financial Report
The Chemours Company is an American chemical company that was founded in July 2015 as a spin-off from DuPont. It has its corporate headquarters in Wilmington, Delaware, United States. Chemours is the manufacturer of Teflon, the brand name of polytetrafluoroethylene (PTFE), known for its anti-stick properties. It also produces titanium dioxide and refrigerant gases.
Revenue
$1.6B
Gross Profit
$308.0M
Operating Profit
$69.0M
Net Profit
$60.0M
Gross Margin
19.8%
Operating Margin
4.4%
Net Margin
3.9%
YoY Growth
-6.4%
EPS
$0.39
Chemours Co Q2 FY2024 Financial Summary
Chemours Co reported revenue of $1.6B (down 6.4% YoY) for Q2 FY2024, with a net profit of $60.0M (up 116.0% YoY) (3.9% margin). Cost of goods sold was $1.2B, operating expenses totaled $239.0M.
Key Financial Metrics
| Total Revenue | $1.6B |
|---|---|
| Net Profit | $60.0M |
| Gross Margin | 19.8% |
| Operating Margin | 4.4% |
| Report Period | Q2 FY2024 |
Revenue Breakdown
Chemours Co Q2 FY2024 revenue of $1.6B breaks down across 3 segments, led by Titanium Technologies at $673.0M (43.3% of total).
| Segment | Revenue | % of Total |
|---|---|---|
| Titanium Technologies | $673.0M | 43.3% |
| Thermal And Specialized Solutions | $513.0M | 33.0% |
| Advanced Performance Materials | $339.0M | 21.8% |
Chemours Co Revenue by Segment — Quarterly Trend
Chemours Co revenue by segment across the last 4 reported quarters, showing how each business line (such as Titanium Technologies and Thermal And Specialized Solutions) has evolved quarter over quarter.
| Segment | Q4 FY2025 | Q3 FY2025 | Q2 FY2025 | Q1 FY2025 |
|---|---|---|---|---|
| Titanium Technologies | $563.0M | $612.0M | $657.0M | $597.0M |
| Thermal And Specialized Solutions | $443.0M | $560.0M | $597.0M | $466.0M |
| Advanced Performance Materials | $312.0M | — | $346.0M | $294.0M |
Chemours Co Annual Revenue by Year
Chemours Co annual revenue history includes year-by-year totals (for example, 2025 revenue was $5.8B).
| Year | Annual Revenue |
|---|---|
| 2025 | $5.8B |
| 2024 | $5.8B |
| 2023 | $6.1B |
| 2022 | $6.8B |
Chemours Co Quarterly Revenue & Net Profit History
Chemours Co results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q4 FY2025 | $1.3B | -2.1% | $-47.0M | -3.5% |
| Q3 FY2025 | $1.5B | -0.9% | $46.0M | 3.1% |
| Q2 FY2025 | $1.6B | +3.9% | $-380.0M | -23.5% |
| Q1 FY2025 | $1.4B | +0.4% | $-5.0M | -0.4% |
| Q4 FY2024 | $1.4B | -0.7% | $-13.0M | -1.0% |
| Q3 FY2024 | $1.5B | +0.5% | $-32.0M | -2.1% |
| Q2 FY2024 | $1.6B | -6.4% | $60.0M | 3.9% |
| Q1 FY2024 | $1.4B | -12.1% | $54.0M | 4.0% |
Income Statement
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.36B | $1.55B | $1.51B | $1.36B | $1.37B | $1.61B | $1.50B | $1.33B |
| YoY Growth | -12.1% | -6.4% | 0.5% | -0.7% | 0.4% | 3.9% | -0.9% | -2.1% |
Balance Sheet
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $7.98B | $7.25B | $7.46B | $7.51B | $7.38B | $7.46B | $7.55B | $7.38B |
| Liabilities | $7.23B | $6.53B | $6.81B | $6.94B | $6.81B | $7.23B | $7.27B | $7.13B |
| Equity | $753.0M | $714.0M | $643.0M | $571.0M | $566.0M | $228.0M | $274.0M | $250.0M |
Cash Flow
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $-290.0M | $-620.0M | $139.0M | $138.0M | $-112.0M | $93.0M | $146.0M | $137.0M |